Synapse - Works

Results (4808)

JANUS 2: A phase III study of survival, tumor response, and symptom response with ruxolitinib plus capecitabine or placebo plus capecitabine in patients with advanced or metastatic pancreatic cancer (mPC) who failed or were intolerant to first-line chemotherapy

Meeting Abstract

O'Reilly, E. M.; Walker, C.; Clark, J.; Brill, K. J.; Dawkins, F. W.; Bendell, J. C.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase 1 results

Meeting Abstract

O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Schultes, B. C.; Rosano, M. E.; Miller, P. J.; Wolf, J.; Flaherty, K.; Ryan, D. P.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay

Meeting Abstract

Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

FAIRLANE: A phase II randomized, double-blind, study of the Akt inhibitor ipatasertib (Ipat, GDC-0068) in combination with paclitaxel (Pac) as neoadjuvant treatment for early stage triple-negative breast cancer (TNBC)

Meeting Abstract

Oliveira, M.; Saura, C.; Gonzalez Martin, A.; Andersen, J. C.; Fisher, J. G.; Calvo, I.; Ciruelos, E.; Gil, M.; de la Pena, L.; Llobet-Canela, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer

Meeting Abstract

O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

HER2 quantification by mass spectrometry compared to IHC or ISH in predicting clinical benefit from anti-HER2 therapy in HER2-positive breast cancer (BC)

Meeting Abstract

Nuciforo, P.; Aura, C.; Thyparambil, S. P.; Vilaro, M.; Garrido-Castro, A. C.; Peg, V.; Jimenez, J.; Hoos, W. A.; Burrows, J.; Hembrough, T. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Temporal trends in health status among adults in the Childhood Cancer Survivor Study (CCSS)

Meeting Abstract

Ness, K. K.; Hudson, M. M.; Jones, K. E.; Leisenring, W. M.; Stovall, M.; Green, D. M.; Neglia, J. P.; Henderson, T. O.; Casillas, J. N.; Ford, J.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Prognostic significance of a diagnosis of multiple lung cancers

Meeting Abstract

Naidoo, J.; Woo, K.; Sima, C. S.; Finley, D. J.; Travis, W. D.; Rusch, V. W.; Kris, M. G.; Zauderer, M. G.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Defining the immunologic phenotype of thymic epithelial tumors

Meeting Abstract

Naidoo, J.; Steele, K.; Sima, C. S.; Yuan, J. D.; Robbins, P. B.; Moreira, A. L.; Pietanza, M. C.; Wolchok, J. D.; Riely, G. J.; Rizvi, N. A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Efficacy and safety of endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors (TKI) after programmed cell death 1 (PD-1) inhibitor treatment in patients with metastatic clear cell renal cell carcinoma (mccRCC)

Meeting Abstract

Nadal, R.; Amin, A.; Geynisman, D. M.; Voss, M. H.; Weinstock, M.; Doyle, J.; Zhang, Z.; Viudez, A.; Plimack, E. R.; McDermott, D. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save